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We read with interest the comment by 
M. E. Elrggal and R. Zyada (Gradual initi­
ation of dialysis as a means to reduce cost 
while providing quality health care. Nat. 
Rev. Nephrol. http://dx.doi.org/10.1038/
nrneph.2017.135; 2017)1 regarding our arti­
cle discussing how to combat costs of kidney 
disease care (Vanholder, R. et al. Reducing the 
costs of chronic kidney disease while deliver­
ing quality health care: a call to action. Nat. 
Rev. Nephrol. 13, 393–409; 2017)2.
In their correspondence, the authors add 
to our proposed approaches to reduce the 
costs of renal replacement therapy, by sug­
gesting the use of incremental haemodialy­
sis (that is, starting patients on dialysis with 
one or two sessions per week instead of the 
habitual three) as another means to reduce 
financial stress on health­care systems. On 
the basis of mathematics alone, this approach 
would undeniably reduce costs. Nevertheless 
we think this concept should be regarded with 
care, as stated in a 2014 comment by mem­
bers of our group3 on a position statement 
 propagating this approach4.
In looking at the conditions that are 
required to consider someone for incremen­
tal dialysis3,4, one might realize that many 
patients initiating dialysis do not match these 
criteria, especially if the 2011 recommenda­
tions to start dialysis only in symptomatic 
patients are taken into account5. Most of 
these restrictions indeed refer to patients with 
symptoms or disorders that lead to condi­
tions necessitating dialysis initiation, such as 
fluid overload, heart failure, hyperkal aemia, 
hyperphosphataemia and mal nutrition. 
Hence, each time dialysis is needed to com­
bat fluid overload (and by extension any 
other symptom or disturbance that would 
necessitate start of dialysis), restricting the 
number of sessions might increase the risk of 
complications due to the irregularity of the 
treatment scheme (for instance, by having to 
remove too much plasma water by ultrafiltra­
tion or by enhancing the so­called ‘saw­tooth 
pattern’ of metabolic markers). On the other 
hand, if a patient has no symptoms, no intrin­
sic need to start dialysis exists, not even at one 
dialysis session per week.
Elrggal and Zyada attribute the high mor­
tality associated with early dialysis to dialysis 
intensity, but no hard data exist to support 
this thesis, and we are not aware of any con­
trolled studies that favour incremental dialy­
sis. Of note, the long weekend interval is a 
notorious cause of dialysis mortality6, which 
is difficult to reconcile with a philosophy 
propagating even longer intervals, and to 
our knowledge the only conclusive controlled 
study on dialysis timeframes showed a sur­
vival advantage of increasing, not decreasing, 
frequency7.
Hence, incremental dialysis might be 
an option for starting haemodialysis, but it 
should in our opinion be applied in carefully 
selected patients. In addition, as this option 
cannot be used in all patients, can only be 
used for the first months of dialysis, after 
which residual kidney function declines, 
and it is very likely that more structural 
inter ventions will be needed2, one won­
ders whether societal financial relief will be 
substantial. How and when to increase the 
frequency of dialysis sessions in these incre­
mental schemes also remains unclear. We 
agree that incremental dialysis might be a 
useful option, especially in low and middle 
income countries like Egypt. However, we 
remain convinced that in those countries as 
well as elsewhere, the options of kidney trans­
plantation, peritoneal dialysis and kidney dis­
ease prevention are underexploited, and that 
it is the responsibility of the nephrological 
communities around the world to propagate 
those solutions, which very likely will have 
more impact on health economics than will 
incremental dialysis.
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